Evaluation of Efficacy of Denosumab in Patients With Thalassemia Major and Osteoporosis: A Randomized, Placebo-controlled, Single-site, Double Blind Phase 2b Clinical Trial
Phase of Trial: Phase II
Latest Information Update: 10 Mar 2017
At a glance
- Drugs Denosumab (Primary)
- Indications Beta-thalassaemia; Osteoporosis
- Focus Therapeutic Use
- 10 Mar 2017 Status changed from active, no longer recruiting to completed.
- 18 Apr 2016 Status changed from recruiting to active, no longer recruiting.
- 29 Jul 2014 New trial record